HOXC8 and Pancreatic Cancer Progression
Author Information
Author(s): Adwan H, Zhivkova-Galunska M, Georges R, Eyol E, Kleeff J, Giese N A, Friess H, Bergmann F, Berger M R
Primary Institution: German Cancer Research Center
Hypothesis
This study investigates the role of HOXC8 in pancreatic ductal adenocarcinoma (PDAC) growth and metastasis.
Conclusion
HOXC8 expression is inversely related to PDAC progression and metastasis.
Supporting Evidence
- HOXC8 mRNA expression was significantly increased in PDAC samples compared to normal tissues.
- Lower HOXC8 levels were associated with higher tumor grades and liver metastases.
- Silencing HOXC8 led to increased proliferation, migration, and colony formation in pancreatic cancer cells.
Takeaway
The study found that a protein called HOXC8 helps slow down the growth and spread of pancreatic cancer. When HOXC8 levels are low, the cancer tends to grow faster.
Methodology
The expression of HOXC8 was measured in PDAC cell lines and human specimens using RT-PCR and immunohistochemistry, and the effects of HOXC8 silencing were tested through functional assays.
Limitations
The study may not account for all factors influencing PDAC progression and metastasis.
Participant Demographics
47 patients with pancreatic cancer (25 women, 22 men, median age 64 years) and 37 patients with chronic pancreatitis (11 women, 26 men, median age 54 years).
Statistical Information
P-Value
P<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website